$41,169,014

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

to VISBY MEDICAL, INC.

healthexpiredONGOING · MOD OF 2021 CONTRACT

WORK BEGAN2021-02-01·LATEST ACTION2026-03-26·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50121C00019_7505_-NONE-_-NONE-

Award description

A RAPID, ACCURATE, POC DISPOSABLE INFLUENZA AND SARS-COV-2 MOLECULAR DIAGNOSTIC

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

The latest obligation on a 2021 contract for rapid point-of-care diagnostics for influenza and SARS-CoV-2.

Sub-sectors

poc-diagnosticsmolecular-diagnosticspandemic-preparedness

Why this matters

Rapid, decentralized diagnostics for dual respiratory pathogens enable early detection and distributed pandemic response, critical for public health infrastructure.

Supply-chain signal

Drives demand for molecular reagents, microfluidic components, and plastics suppliers; manufacturing scale-up supports domestic diagnostic capacity.

U.S.–China competition angle

Reduces U.S. dependence on Chinese-manufactured diagnostics; develops domestic POC testing capacity—strategic for pandemic resilience and biosecurity.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-13. Cost: $0.016748.

Period of performance

Start

2021-02-01

End

2026-05-31

Status

expired44 days ago

Recipient

VISBY MEDICAL, INC.

UEI LWNQZECSVHY1

View full profile →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50121C00019_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.